EVOLUTION OF THE ETIOTROPIC TREATMENT OF SHIGELLOSIS
The article tells about the evolution of the etiotropic treatment of patients with shigellosis. The key principles of treatment of the disease are demonstrated. Taking into account the variability of the pathogen, the etiotropic use of fluoroquinolones in the 90s of the 20th century is substantiated. The dynamics of shigella infection in the Russian Federation over the past 15 years against a background of fluoroquinolones is highlighted..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - year:2017 |
---|---|
Enthalten in: |
Медицинский совет - (2017), 4, Seite 79-80 |
Sprache: |
Russisch |
---|
Beteiligte Personen: |
V. V. NIKIFOROV [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
---|
doi: |
10.21518/2079-701X-2017-4-79-80 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ023230746 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ023230746 | ||
003 | DE-627 | ||
005 | 20230505014146.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2017 xx |||||o 00| ||rus c | ||
024 | 7 | |a 10.21518/2079-701X-2017-4-79-80 |2 doi | |
035 | |a (DE-627)DOAJ023230746 | ||
035 | |a (DE-599)DOAJda6b4af7eb5d47988553a3185da69452 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a rus | ||
100 | 0 | |a V. V. NIKIFOROV |e verfasserin |4 aut | |
245 | 1 | 0 | |a EVOLUTION OF THE ETIOTROPIC TREATMENT OF SHIGELLOSIS |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The article tells about the evolution of the etiotropic treatment of patients with shigellosis. The key principles of treatment of the disease are demonstrated. Taking into account the variability of the pathogen, the etiotropic use of fluoroquinolones in the 90s of the 20th century is substantiated. The dynamics of shigella infection in the Russian Federation over the past 15 years against a background of fluoroquinolones is highlighted. | ||
650 | 4 | |a shigellosis | |
650 | 4 | |a etiotropic treatment | |
650 | 4 | |a fluoroquinolones | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a M. Z. SHAKHMARDANOV |e verfasserin |4 aut | |
700 | 0 | |a S. V. BUROVA |e verfasserin |4 aut | |
700 | 0 | |a U. N. TOMILIN |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Медицинский совет |d Remedium Group LLC, 2019 |g (2017), 4, Seite 79-80 |w (DE-627)DOAJ000029483 |x 26585790 |7 nnns |
773 | 1 | 8 | |g year:2017 |g number:4 |g pages:79-80 |
856 | 4 | 0 | |u https://doi.org/10.21518/2079-701X-2017-4-79-80 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/da6b4af7eb5d47988553a3185da69452 |z kostenfrei |
856 | 4 | 0 | |u https://www.med-sovet.pro/jour/article/view/1856 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2079-701X |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2658-5790 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |j 2017 |e 4 |h 79-80 |